New AI Platform to Analyze NHS Radiological Scans
|
By HospiMedica International staff writers Posted on 30 May 2019 |

Image: The DGX-2 two petaFLOPS supercomputer system (Photo courtesy of Nvidia).
A novel artificial intelligence (AI) system intended for the United Kingdom National Health Service (NHS; London) will automate nationwide radiological interpretation across multiple clinical pathways, including oncology, cardiology, and neurology.
The AI project is a joint effort of Nvidia (Santa Clara, CA, USA) and King’s College London (KCL; United Kingdom), which will build and train the AI platform to interpret radiological scans for hospitals across the UK. The technology would thus free up overworked specialists and could also lead to breakthroughs across the medical imaging landscape, from determining the root cause of various cancers to helping classify specific neurological impairments and identifying optimal treatment plans.
At the core of the first stage of the project is a graphics processing unit (GPU)-powered two-petaflops Nvidia DGX-2 supercomputer, combining 16 interconnected GPUs, which Nvidia claims is currently the world's most powerful AI system. The project will also employ the Nvidia Clara AI toolkit, an open-source NiftyNet image-analysis neural-network, and a host of supplemental imaging technologies from existing NHS partners such as Kheiron Medical (London, UK), Mirada (London, UK) and Scan.
“Together with King's College London, we're working to push the envelope in AI for healthcare,” said Jaap Zuiderveld, vice president for Europe, the Middle East and Africa (EMEA) at Nvidia. “DGX-2 systems with the Nvidia Clara platform will enable the project to scale and drive breakthroughs in radiology [and] ultimately help improve patient outcomes within the NHS.”
“This center marks a significant chapter in the future of AI-enabled NHS hospitals, and the infrastructure is an essential part of building new AI tools which will benefit patients and the healthcare system as a whole,” said Professor Sebastien Ourselin, PhD, head of the School of Biomedical Engineering & Imaging Sciences at KCL. “The Nvidia DGX-2 AI system's large memory and massive computing power make it possible for us to tackle training of large, 3D datasets in minutes instead of days while keeping the data secure on the premises of the hospital.”
As security and governance of data in clinical environments is of the highest importance, and since AI models within the project will be built from patient data from across the entire UK-wide NHS system, the center has decided to employ federated learning, which keeps data within its own, secure domain, while allowing algorithms to be developed at multiple sites using data located at hospitals around the UK. The federated learning approach is designed to ensure a robust and secure system that more than complies with government data-privacy requirements.
The AI project is a joint effort of Nvidia (Santa Clara, CA, USA) and King’s College London (KCL; United Kingdom), which will build and train the AI platform to interpret radiological scans for hospitals across the UK. The technology would thus free up overworked specialists and could also lead to breakthroughs across the medical imaging landscape, from determining the root cause of various cancers to helping classify specific neurological impairments and identifying optimal treatment plans.
At the core of the first stage of the project is a graphics processing unit (GPU)-powered two-petaflops Nvidia DGX-2 supercomputer, combining 16 interconnected GPUs, which Nvidia claims is currently the world's most powerful AI system. The project will also employ the Nvidia Clara AI toolkit, an open-source NiftyNet image-analysis neural-network, and a host of supplemental imaging technologies from existing NHS partners such as Kheiron Medical (London, UK), Mirada (London, UK) and Scan.
“Together with King's College London, we're working to push the envelope in AI for healthcare,” said Jaap Zuiderveld, vice president for Europe, the Middle East and Africa (EMEA) at Nvidia. “DGX-2 systems with the Nvidia Clara platform will enable the project to scale and drive breakthroughs in radiology [and] ultimately help improve patient outcomes within the NHS.”
“This center marks a significant chapter in the future of AI-enabled NHS hospitals, and the infrastructure is an essential part of building new AI tools which will benefit patients and the healthcare system as a whole,” said Professor Sebastien Ourselin, PhD, head of the School of Biomedical Engineering & Imaging Sciences at KCL. “The Nvidia DGX-2 AI system's large memory and massive computing power make it possible for us to tackle training of large, 3D datasets in minutes instead of days while keeping the data secure on the premises of the hospital.”
As security and governance of data in clinical environments is of the highest importance, and since AI models within the project will be built from patient data from across the entire UK-wide NHS system, the center has decided to employ federated learning, which keeps data within its own, secure domain, while allowing algorithms to be developed at multiple sites using data located at hospitals around the UK. The federated learning approach is designed to ensure a robust and secure system that more than complies with government data-privacy requirements.
Latest AI News
- Machine Learning Approach Enhances Liver Cancer Risk Stratification
- New AI Approach Monitors Brain Health Using Passive Wearable Data
- AI Tool Maps Early Risk Patterns in Bloodstream Infections
- AI Model Identifies Rare Endocrine Disorder from Hand Images
- AI Tool Promises to Reduce Length of Hospital Stays and Free Up Beds
- Machine Learning Model Cuts Canceled Liver Transplants By 60%
Channels
Critical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read moreSurgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







